Patent · US Active

3,3,7,7-tetrakis(difluoramino)octahydro-1,5-diazocinium salts

US8444783B1 · kind B1 · utility

0Cited by
2References
5Claims
0Family size

Inventors

Key dates

Filing dateJun 5, 2009
Grant dateMay 21, 2013
Priority date
Expiry dateMar 21, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D245/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

3,3,7,7-Tetrakis(difluoramino)octahydro-1,5-diazocinium intermediate salts through difluoramination followed by N-denosylation or N-deprotection, which are valuable for use as precursor(s) to HNFX as well as to other members of the rare class of 3,3,7,7-tetrakis(difluoramino)octahydro-1,5-diazocines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.